Lexaria Bioscience (LEXX) Price to Sales (2021 - 2026)
Lexaria Bioscience's (LEXX) Price to Sales was 49.06 for fiscal Q3 2026 (quarter ended May 31, 2026), up 87.4% from 26.18 a year earlier and up 63.4% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Price to Sales (2021 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Price to Sales at Lexaria Bioscience was 8.25, down 85.2% from FY2024.
- By fiscal year, Price to Sales came in at 55.70 in FY2024 (+81.4%), 30.70 in FY2023 (-55.5%), 68.97 in FY2022 (+82.5%) and 37.79 in FY2021.
- The fiscal Q3 2026 figure ranks as the highest quarterly Price to Sales since fiscal Q1 2025.
- Year over year, Price to Sales gained in three of the last eight quarters, with growth averaging 16.6%.
- The high point for year-over-year Price to Sales in five years was fiscal Q3 2024 (growth of 858.3%); the low point was fiscal Q4 2025 (a decline of 85.2%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at 30.02 (Q2 2026), 33.01 (Q1 2026) and 19.71 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 49.06 |
| Feb 28, 2026 | 30.02 |
| Nov 30, 2025 | 33.01 |
| Aug 31, 2025 | 19.71 |
| May 31, 2025 | 26.18 |
| Feb 28, 2025 | 44.19 |
| Nov 30, 2024 | 66.18 |
| Aug 31, 2024 | 133.15 |
| May 31, 2024 | 149.63 |
| Feb 29, 2024 | 105.60 |
| Nov 30, 2023 | 55.29 |
| Aug 31, 2023 | 30.70 |
| May 31, 2023 | 15.61 |
| Feb 28, 2023 | 54.87 |
| Nov 30, 2022 | 51.92 |
| Aug 31, 2022 | 68.97 |
| May 31, 2022 | 69.61 |
| Feb 28, 2022 | 75.56 |
| Nov 30, 2021 | 68.83 |
| Aug 31, 2021 | 37.79 |
API Access
Lexaria Bioscience Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();